Physicians and researchers from the University of Florida will participate in the virtual American Association for Cancer Research Annual Meeting being held on April 10-15, 2021. AACR is a premier event in cancer research. The AACR Annual Meeting program covers the latest discoveries across the spectrum of cancer research—from…
In March, the Florida Department of Health announced the award of 10 grants totaling $4.9 million to nine UF Health Cancer Center investigators. The grants were provided through the state’s Live Like Bella Pediatric Cancer Research Initiative, the James and Esther King Biomedical Research Program and the…
Merry Jennifer Markham, M.D., FACP, FASCO, associate director for medical affairs at the UF Health Cancer Center and professor in the UF division of hematology and oncology, has been appointed as chief of the division of hematology and oncology in the UF College of Medicine. Dr. Merry Jennifer Markham “It…
Health conditions, lifestyle choices and family history can all increase your risk of heart disease. But did you know that cancer and heart disease have been linked?
UF Health Cancer Center researchers Drs. Zhang, Zhou and Zheng Immunotherapy is a type of cancer treatment designed to boost the body’s natural defenses to fight the cancer. It uses substances either made by the body or in a laboratory to improve or restore immune system function, according to…
Dr. Joseph V. Simone We are saddened to share the news that Joseph V. Simone, M.D., former UF Health Cancer Center director and pioneering clinical investigator, passed away January 21, 2021, at the age of 85.An internationally recognized leader in cancer care, research and education, Simone’s research led…
Drs. Angel Sampson and Andria Doty recently teamed up with Dr. Jatinder Lamba in the department of pharmacotherapy and translational research in the UF College of Pharmacy, and Dr. Soheil Meshinchi at the Fred Hutchinson Cancer Research Center, University of Washington, in an effort to further understand the therapeutic relevance of various forms of the CD33 protein as it relates to the antibody-drug therapy. CD33 is expressed on malignant cancer cells in nearly all patients with acute myeloid leukemia (AML) and there has been a long-standing interest in the development of CD33-directed monoclonal antibodies for the treatment of AML.
On Jan. 8, the Florida Cancer Control and Research Advisory Council (CCRAB), North Central Florida Cancer Control Collaborative (NCFCCC), and UF Health Cancer Center hosted Cancer in the Time of Coronavirus: The COVID-19 Vaccine webinar on Zoom. In this webinar, speakers Christopher Cogle, M.D., and…
The UF Health Cancer Center’s first ever Virtual Research Symposium was a huge success. Watch a recording of the keynote address, see trainee award winners and more below.
Merry Jennifer Markham, M.D., FACP, FASCO, associate director for medical affairs at the UF Health Cancer Center and professor in the UF Division of Hematology and Oncology, has been elected to the American Society of Clinical Oncology (ASCO) Nominating Committee. Dr. Markham’s election marks the first…
